Blood pressure control and nephroprotection in diabetes.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
Works matching IS 00912700 AND DT 2004 AND VI 44 AND IP 4
Results: 23
1
2
Intense management of diabetes mellitus: role of glucose control and antiplatelet agents.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
3
Epidemiology of diabetes.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
4
Preventing type II diabetes mellitus.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
5
The pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor, are unaffected by a single dose of alcohol.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
6
Pharmacokinetics of sumatriptan nasal spray in children.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
7
Serum metabolite/caffeine ratios as a test for liver function.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
8
Preventing contrast nephropathy: what is the best strategy? A review of the literature.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
9
Diabetes Mellitus: An Imperative for Prevention and Intense Management.
- Published in:
- Journal of Clinical Pharmacology, 2004, v. 44, n. 4, p. 394
- By:
- Publication type:
- Article
10
The Pharmacokinetics and Pharmacodynamics of Ximelagatran, an Oral Direct Thrombin Inhibitor, Are Unaffected by a Single Dose of Alcohol.
- Published in:
- Journal of Clinical Pharmacology, 2004, v. 44, n. 4, p. 388
- By:
- Publication type:
- Article
11
No Clinically Relevant CYP3A Induction with the Dual Angiotensin-Converting Enzyme/Neutral Endopeptidase Inhibitor, M100240.
- Published in:
- Journal of Clinical Pharmacology, 2004, v. 44, n. 4, p. 379
- By:
- Publication type:
- Article
12
Influence of Azimilide on CYP2C19-Mediated Metabolism.
- Published in:
- Journal of Clinical Pharmacology, 2004, v. 44, n. 4, p. 373
- By:
- Publication type:
- Article
13
Assessment of Visual Analog versus Categorical Scale for Measurement of Osteoarthritis Pain.
- Published in:
- Journal of Clinical Pharmacology, 2004, v. 44, n. 4, p. 368
- By:
- Publication type:
- Article
14
Pharmacokinetics of Sumatriptan Nasal Spray in Children.
- Published in:
- Journal of Clinical Pharmacology, 2004, v. 44, n. 4, p. 359
- By:
- Publication type:
- Article
15
Estimating Mass Balance for Inhaled Drugs in Humans: An Example with a VLA-4 Antagonist, IVL745.
- Published in:
- Journal of Clinical Pharmacology, 2004, v. 44, n. 4, p. 348
- By:
- Publication type:
- Article
16
Serum Metabolite/Caffeine Ratios as a Test for Liver Function.
- Published in:
- Journal of Clinical Pharmacology, 2004, v. 44, n. 4, p. 338
- By:
- Publication type:
- Article
17
American College of Clinical Pharmocology.
- Published in:
- Journal of Clinical Pharmacology, 2004, v. 44, n. 4, p. 439
- Publication type:
- Article
18
Blood Pressure Control and Nephroprotection in Diabetes.
- Published in:
- Journal of Clinical Pharmacology, 2004, v. 44, n. 4, p. 431
- By:
- Publication type:
- Article
19
Clinical Trials and Lipid Guidelines for Type II Diabetes.
- Published in:
- Journal of Clinical Pharmacology, 2004, v. 44, n. 4, p. 423
- By:
- Publication type:
- Article
20
Intense Management of Diabetes Mellitus: Role of Glucose Control and Antiplatelet Agents.
- Published in:
- Journal of Clinical Pharmacology, 2004, v. 44, n. 4, p. 414
- By:
- Publication type:
- Article
21
Preventing Type II Diabetes Mellitus.
- Published in:
- Journal of Clinical Pharmacology, 2004, v. 44, n. 4, p. 406
- By:
- Publication type:
- Article
22
Epidemiology of Diabetes.
- Published in:
- Journal of Clinical Pharmacology, 2004, v. 44, n. 4, p. 397
- By:
- Publication type:
- Article
23
Preventing Contrast Nephropathy: What is the Best Strategy? A Review of the Literature.
- Published in:
- Journal of Clinical Pharmacology, 2004, v. 44, n. 4, p. 327
- By:
- Publication type:
- Article